Published in Emerg Infect Dis on September 01, 1998
Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. Clin Microbiol Rev (2000) 4.59
Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya. JAMA (2006) 3.31
Pneumonia research to reduce childhood mortality in the developing world. J Clin Invest (2008) 2.01
Epidemiology of Haemophilus influenzae serotype a, North American Arctic, 2000-2005. Emerg Infect Dis (2008) 1.50
Effect of O acetylation of Neisseria meningitidis serogroup A capsular polysaccharide on development of functional immune responses. Infect Immun (2002) 1.49
Invasive disease due to nontypeable Haemophilus influenzae among children in Arkansas. J Clin Microbiol (2003) 1.46
Increasing incidence of invasive Haemophilus influenzae disease in adults, Utah, USA. Emerg Infect Dis (2011) 1.10
Invasive bacterial diseases in northern Canada. Emerg Infect Dis (2008) 0.98
Haemophilus influenzae type a infection and its prevention. Infect Immun (2007) 0.97
Community acquired bacterial meningitis in Cuba: a follow up of a decade. BMC Infect Dis (2010) 0.96
Toward elimination of Haemophilus influenzae type B carriage and disease among high-risk American Indian children. Am J Public Health (2000) 0.95
Genomic variability of Haemophilus influenzae isolated from Mexican children determined by using enterobacterial repetitive intergenic consensus sequences and PCR. J Clin Microbiol (2000) 0.90
Bacterial meningitis in children and adolescents: an observational study based on the national surveillance system. BMC Infect Dis (2005) 0.90
Efficacy of Haemophilus influenzae type b conjugate vaccines and persistence of disease in disadvantaged populations. The Haemophilus Influenzae Study Group. Am J Public Health (1999) 0.88
Haemophilus influenzae: using comparative genomics to accurately identify a highly recombinogenic human pathogen. BMC Genomics (2015) 0.86
Invasive Haemophilus influenzae in the United States, 1999-2008: epidemiology and outcomes. J Infect (2012) 0.84
Hospitalizations for vaccine preventable pneumonias in patients with inflammatory bowel disease: a 6-year analysis of the Nationwide Inpatient Sample. Clin Exp Gastroenterol (2013) 0.84
Population subdivision and the detection of recombination in non-typable Haemophilus influenzae. Microbiology (2012) 0.82
Developing the right pneumococcal vaccine for the time and place. Am J Trop Med Hyg (2010) 0.81
Population-based surveillance of Hib invasive infections in children in British Columbia Alberta and Ontario - 1995 to 1997. Can J Infect Dis (2000) 0.81
Immunologic response to Haemophilus influenzae type b (Hib) conjugate vaccine and risk factors for carriage among Hib carriers and noncarriers in Southwestern Alaska. Clin Vaccine Immunol (2006) 0.80
Towards a liquid self: how time, geography, and life experiences reshape the biological identity. Front Immunol (2014) 0.80
Treatment of Haemophilus bacteremia with benzylpenicillin is associated with increased (30-day) mortality. BMC Infect Dis (2012) 0.79
Development and Optimization of a Homemade ELISA Kit for Detection of Antibodies Against Haemophilus influenzae Type b. Jundishapur J Microbiol (2016) 0.75
Pertussis in Florida, 2000-2006: trends in a historically low-incidence state. Public Health Rep (2010) 0.75
Haemophilus influenzae type b disease and vaccine booster dose deferral, United States, 1998-2009. Pediatrics (2012) 0.75
Decline of childhood Haemophilus influenzae type b (Hib) disease in the Hib vaccine era. JAMA (1993) 4.63
Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease. Clin Infect Dis (1992) 2.55
Invasive Haemophilus influenzae disease in adults. A prospective, population-based surveillance. CDC Meningitis Surveillance Group. Ann Intern Med (1992) 2.33
Immunization of US children with Hemophilus influenzae type b polysaccharide vaccine. A cost-effectiveness model of strategy assessment. JAMA (1985) 1.91
Patient-specific reminder letters and pediatric well-child-care show rates. Clin Pediatr (Phila) (1994) 1.49
The reporting of communicable diseases: a controlled study of Neisseria meningitidis and Haemophilus influenzae infections. Clin Infect Dis (1995) 1.46
Progress toward elimination of Haemophilus influenzae type b disease among infants and children--United States, 1987-1995. MMWR Morb Mortal Wkly Rep (1996) 1.45
Primary invasive Haemophilus influenzae type b disease: a population-based assessment of risk factors. J Pediatr (1986) 1.40
Conjugate vaccines and the carriage of Haemophilus influenzae type b. Emerg Infect Dis (1996) 1.39
Carriage of Haemophilus influenzae type b in children after widespread vaccination with conjugate Haemophilus influenzae type b vaccines. Pediatr Infect Dis J (1993) 1.36
Invasive Haemophilus influenzae type b disease in Alaska: background epidemiology for a vaccine efficacy trial. J Infect Dis (1986) 1.28
Haemophilus influenzae infections in Fresno County, California: a prospective study of the effects of age, race, and contact with a case on incidence of disease. J Infect Dis (1980) 1.26
Reported vaccine-preventable diseases--United States, 1993, and the childhood immunization initiative. MMWR Morb Mortal Wkly Rep (1994) 1.21
National, state, and urban area vaccination coverage levels among children aged 19-35 months--United States, January-December 1995. MMWR Morb Mortal Wkly Rep (1997) 1.01
Invasive Haemophilus influenzae infections in older children and adults in Seattle. Clin Infect Dis (1993) 0.98
Prospective surveillance of Haemophilus influenzae type b disease in Dallas County, Texas, and in Minnesota. Pediatrics (1987) 0.97
Spectrum of invasive Haemophilus influenzae type b disease in adults. Arch Intern Med (1990) 0.96
Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination coverage by age 2 years--linkage of vaccination and WIC services. MMWR Morb Mortal Wkly Rep (1996) 0.96
Recommendations of the Advisory Committee on Immunization Practices: programmatic strategies to increase vaccination rates--assessment and feedback of provider-based vaccination coverage information. MMWR Morb Mortal Wkly Rep (1996) 0.95
Retracted Development of a vaccine tracking system to improve the rate of age-appropriate primary immunization in children of lower socioeconomic status. J Pediatr (1995) 0.89
Effectiveness of computer-generated telephone messages in increasing clinic visits. Arch Pediatr Adolesc Med (1995) 0.88
Invasive Haemophilus influenzae infections in men with HIV infection. JAMA (1992) 0.84
Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis (2001) 11.73
Meningococcal disease. N Engl J Med (2001) 8.50
Serological response to "Rochalimaea henselae" antigen in suspected cat-scratch disease. Lancet (1992) 6.48
Bacterial meningitis in the United States in 1995. Active Surveillance Team. N Engl J Med (1997) 5.73
Cat scratch disease in Connecticut. Epidemiology, risk factors, and evaluation of a new diagnostic test. N Engl J Med (1993) 5.45
Intussusception among infants given an oral rotavirus vaccine. N Engl J Med (2001) 5.33
The changing epidemiology of meningococcal disease in the United States, 1992-1996. J Infect Dis (1999) 4.37
Emergency vaccination against epidemic meningitis in Ghana: implications for the control of meningococcal disease in West Africa. Lancet (2000) 4.35
Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis (1998) 3.97
The epidemiology of candidemia in two United States cities: results of a population-based active surveillance. Clin Infect Dis (1999) 3.92
Immunogenicity of 2 serogroup B outer-membrane protein meningococcal vaccines: a randomized controlled trial in Chile. JAMA (1999) 3.69
Changing epidemiology of pertussis in the United States: increasing reported incidence among adolescents and adults, 1990-1996. Clin Infect Dis (1999) 3.48
Cost-effectiveness of a routine varicella vaccination program for US children. JAMA (1994) 3.27
Efficacy of meningococcal vaccine and barriers to vaccination. JAMA (1998) 2.92
Clinical signs for the recognition of children with moderate or severe anaemia in western Kenya. Bull World Health Organ (1997) 2.73
Protective efficacy of a serogroup B meningococcal vaccine in Sao Paulo, Brazil. Lancet (1992) 2.52
Reemergence of invasive Haemophilus influenzae type b disease in a well-vaccinated population in remote Alaska. J Infect Dis (1999) 2.32
Cat scratch disease in the United States: an analysis of three national databases. Am J Public Health (1993) 2.26
Fatal respiratory disease due to Corynebacterium diphtheriae: case report and review of guidelines for management, investigation, and control. Clin Infect Dis (1993) 2.21
Molecular epidemiology of diphtheria in Russia, 1985-1994. J Infect Dis (1996) 2.12
Evaluation of pulsed-field gel electrophoresis in epidemiological investigations of meningococcal disease outbreaks caused by Neisseria meningitidis serogroup C. J Clin Microbiol (2001) 2.12
Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. JAMA (1997) 1.99
Risk factors for meningococcal disease in college students. JAMA (2001) 1.94
Risk factors for severe pulmonary and disseminated coccidioidomycosis: Kern County, California, 1995-1996. Clin Infect Dis (2001) 1.82
Pertussis deaths: report of 23 cases in the United States, 1992 and 1993. Pediatrics (1996) 1.79
Application of PCR for detection of toxigenic Corynebacterium diphtheriae strains isolated during the Russian diphtheria epidemic, 1990 through 1994. J Clin Microbiol (1995) 1.76
Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. J Infect Dis (2000) 1.76
Factors determining prevalence of maternal antibody to measles virus throughout infancy: a review. Clin Infect Dis (2000) 1.67
Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg (2001) 1.66
Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule. JAMA (1996) 1.64
Diphtheria in the former Soviet Union: reemergence of a pandemic disease. Emerg Infect Dis (1999) 1.61
Assessment of potential indicators for protein-energy malnutrition in the algorithm for integrated management of childhood illness. Bull World Health Organ (1997) 1.61
Reporting efficiency during a measles outbreak in New York City, 1991. Am J Public Health (1993) 1.53
Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management. Diabetes Metab Res Rev (2011) 1.50
Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies. Am J Epidemiol (1999) 1.48
Distribution of Neisseria meningitidis serogroup B serosubtypes and serotypes circulating in the United States. The Active Bacterial Core Surveillance Team. J Clin Microbiol (2000) 1.48
Abscesses due to mycobacterium abscessus linked to injection of unapproved alternative medication. Emerg Infect Dis (1999) 1.47
Leptospirosis among patients presenting with dengue-like illness in Puerto Rico. Acta Trop (2005) 1.45
Circulating immune complexes in patients with acquired immune deficiency syndrome contain the AIDS-associated retrovirus. Clin Immunol Immunopathol (1986) 1.44
Epidemic meningococcal disease in Nairobi, Kenya, 1989. The Kenya/Centers for Disease Control (CDC) Meningitis Study Group. J Infect Dis (1992) 1.43
Exudative pharyngitis possibly due to Corynebacterium pseudodiphtheriticum, a new challenge in the differential diagnosis of diphtheria. Emerg Infect Dis (1997) 1.43
Evaluation of three screening tests and a risk assessment model for diagnosing peripheral neuropathy in the diabetes clinic. Diabetes Res Clin Pract (2001) 1.41
Diversity and prevalence of PorA types in Neisseria meningitidis serogroup B in the United States, 1992-1998. J Infect Dis (2000) 1.41
Successful control of epidemic diphtheria in the states of the Former Union of Soviet Socialist Republics: lessons learned. J Infect Dis (2000) 1.41
Septic arthritis due to Micrococcus luteus. J Rheumatol (1986) 1.39
Access and outcomes among minority transplant patients, 1999-2008, with a focus on determinants of kidney graft survival. Am J Transplant (2010) 1.38
Toxic shock syndrome in the United States: surveillance update, 1979 1996. Emerg Infect Dis (2000) 1.35
Serologic responses to Bartonella and Afipia antigens in patients with cat scratch disease. Pediatrics (1995) 1.33
Are we ready for diphtheria? A report from the Diphtheria Diagnostic Workshop, Atlanta, 11 and 12 July 1994. J Infect Dis (1995) 1.32
Tobacco smoke as a risk factor for meningococcal disease. Pediatr Infect Dis J (1997) 1.30
Molecular epidemiology of Bordetella pertussis by pulsed-field gel electrophoresis profile: Cincinnati, 1989-1996. J Infect Dis (2001) 1.29
Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy. Diabet Med (2011) 1.26
The pattern of involvement of adult-onset acid maltase deficiency at autopsy. Muscle Nerve (1987) 1.25
Small animals are not susceptible to human immunodeficiency virus infection. J Gen Virol (1987) 1.24
Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med (1994) 1.23
Pertussis infection among adults during the 1993 outbreak in Chicago. J Infect Dis (1995) 1.21
Evaluation of a method for detecting aberrations in public health surveillance data. Am J Epidemiol (1993) 1.21
Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy. Diabet Med (2009) 1.20
Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. Am J Epidemiol (1994) 1.20
Excess mortality from stomach cancer, lung cancer, and asbestosis and/or mesothelioma in crocidolite mining districts in South Africa. Am J Epidemiol (1986) 1.20
Epidemic-associated Neisseria meningitidis detected by multilocus enzyme electrophoresis. Emerg Infect Dis (1996) 1.19
Resolving disagreements in the patient-physician relationship: tools for improving communication in managed care. JAMA (1999) 1.17
Non-insulin-dependent diabetes mellitus among First Nations children. New entity among First Nations people of north western Ontario. Can Fam Physician (1996) 1.17
Crescentic glomerulonephritis in children. Pediatr Nephrol (1992) 1.14
Case 22-1992--pathogenesis of cat scratch disease. N Engl J Med (1992) 1.13
Antimicrobial resistance of Neisseria meningitidis in the United States, 1997. The Active Bacterial Core Surveillance (ABCs) Team. Clin Infect Dis (2000) 1.12
Measles eradication: is it in our future? Am J Public Health (2000) 1.12
Tetanus surveillance--United States, 1989-1990. MMWR CDC Surveill Summ (1992) 1.09
Neisseria meningitidis serogroup B outer membrane vesicle vaccine in adults with occupational risk for meningococcal disease. Vaccine (1999) 1.07
Evidence for transmission of pertussis in schools, Massachusetts, 1996: epidemiologic data supported by pulsed-field gel electrophoresis studies. J Infect Dis (2000) 1.07
Clinical characteristics and management of 676 hospitalized diphtheria cases, Kyrgyz Republic, 1995. J Infect Dis (2000) 1.06
Outbreak of coccidioidomycosis in Washington state residents returning from Mexico. Clin Infect Dis (2000) 1.06
Suspected Brazilian purpuric fever in a toddler with overwhelming Epstein-Barr virus infection. Clin Infect Dis (1998) 1.06
Early detection and response to meningococcal disease epidemics in sub-Saharan Africa: appraisal of the WHO strategy. Bull World Health Organ (2002) 1.05
Predicting chemotherapy response to paclitaxel-based therapy in advanced non-small-cell lung cancer with P-glycoprotein expression. Respiration (2003) 1.04
Tetanus surveillance--United States, 1995-1997. MMWR CDC Surveill Summ (1998) 1.03
Risk factors for acute symptomatic coccidioidomycosis among elderly persons in Arizona, 1996-1997. J Infect Dis (2000) 1.03
Think globally, act locally: the role of local demographics and vaccination coverage in the dynamic response of measles infection to control. Philos Trans R Soc Lond B Biol Sci (2013) 1.02
Childhood tuberculosis and tuberculous meningitis: high incidence rates in the Western Cape of South Africa. Tuber Lung Dis (1992) 1.02
Variables associated with corneal confocal microscopy parameters in healthy volunteers: implications for diabetic neuropathy screening. Diabet Med (2012) 1.02
The effect of Edmonston-Zagreb and Schwarz measles vaccines on immune response in infants. J Infect Dis (1996) 1.01
Combined immunosuppression for the treatment of idiopathic giant cell myocarditis. Mayo Clin Proc (1999) 1.01
Pertussis surveillance--United States, 1989-1991. MMWR CDC Surveill Summ (1992) 1.01
Vaccine-associated paralytic poliomyelitis and HIV infection. Lancet (1994) 1.00
Diphtheria toxoid vaccine effectiveness: A case-control study in Russia. J Infect Dis (2000) 1.00
Update on Haemophilus influenzae serotype b and meningococcal vaccines. Pediatr Clin North Am (2000) 0.99
Criteria for the notification of childhood tuberculosis in a high-incidence area of the western Cape Province. S Afr Med J (1990) 0.98
[Isolation of Haemophilus aegyptius associated with Brazilian purpuric fever, of Chloropidae (Diptera) of the genera Hippelates and Liohippelates]. Rev Inst Med Trop Sao Paulo (1995) 0.97
Coccidioidomycosis in human immunodeficiency virus-infected persons in Arizona, 1994-1997: incidence, risk factors, and prevention. J Infect Dis (2000) 0.97
Pertussis outbreak in an elementary school with high vaccination coverage. Pediatr Infect Dis J (2001) 0.96
Respiratory diphtheria in the United States, 1980 through 1995. Am J Public Health (1998) 0.95
Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough. Clin Infect Dis (1995) 0.95
Clinicopathologic review of twelve children with nephropathy, Wilms tumor, and genital abnormalities (Drash syndrome). J Pediatr (1990) 0.95
Recipient to donor conduction of atrial tachycardia following orthotopic heart transplantation. Pacing Clin Electrophysiol (1998) 0.94
Preparing for elimination of congenital Rubella syndrome (CRS): summary of a workshop on CRS elimination in the United States. Clin Infect Dis (2000) 0.94